Trials / Completed
CompletedNCT02272517
Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder
An Interventional, Randomised, Double-blind, Parallel-group, Active-comparator, Flexible-dose Study on the Efficacy of Vortioxetine Versus Escitalopram on Cognitive Dysfunction in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at evaluating the effect of vortioxetine on cognitive dysfunction in major depressive disorder (MDD) patients with inadequate response to current antidepressant treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vortioxetine 10-20 mg | |
| DRUG | Escitalopram 10-20 mg |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2014-10-23
- Last updated
- 2017-02-28
Locations
16 sites across 4 countries: Finland, Germany, Serbia, Slovakia
Source: ClinicalTrials.gov record NCT02272517. Inclusion in this directory is not an endorsement.